This study tests a combination of an immunotherapy drug (cemiplimab) and two low-dose chemotherapy drugs (paclitaxel and carboplatin) in people whose head and neck cancer has returned or spread. The goal is to see if this mix can shrink tumors better than standard treatments. Abo…
Phase: PHASE2 • Sponsor: Marcelo Bonomi • Aim: Disease control
Last updated May 01, 2026 15:59 UTC